IVERMECTIN 0.5%

1 FDA products 1 manufacturers TOPICAL

IVERMECTIN 0.5% is an active ingredient listed in 1 FDA drug label records from 1 manufacturers taken by topical route marketed mainly as human otc drug products.

About IVERMECTIN 0.5%

IVERMECTIN 0.5% appears as the active ingredient in 1 FDA drug label records. These products are produced by 1 distinct manufacturers, with the largest catalogues from Guangxi Keyun E-commerce Co., Ltd.. In this ingredient’s product set, the most common route of administration is topical. Approved labelling for these products most frequently references: lice treatment. Every record below is taken from FDA Structured Product Labelling data; use it to compare brand names, strengths and manufacturers before speaking with a pharmacist.

How it is supplied

Dosage formProductsRouteProducts
— — TOPICAL 1
— — — —
— — — —
— — — —
— — — —
— — — —

Main manufacturers

ManufacturerProductsMarketing type
Guangxi Keyun E-commerce Co., Ltd. 1 HUMAN OTC DRUG

FDA drug products containing IVERMECTIN 0.5%

Brand nameManufacturerTypeRouteDosage form
Scalp Care Lotions Guangxi Keyun E-commerce Co., Ltd. HUMAN OTC DRUG TOPICAL

Frequently asked questions

How many FDA drug products contain IVERMECTIN 0.5%?
1 FDA drug label records list IVERMECTIN 0.5% as the active ingredient, supplied by 1 manufacturers. The table below lists the brand names, manufacturers and dosage forms covered by those labels.

Which companies make IVERMECTIN 0.5% products?
The manufacturers with the most IVERMECTIN 0.5% label records are Guangxi Keyun E-commerce Co., Ltd.. Generic and brand versions may be produced by different companies.

Is this a substitute for medical advice?
No. This page reproduces FDA labelling data so you can identify a product and its manufacturer. Dosing, interactions and suitability must be confirmed with a prescriber or pharmacist.

This page reproduces FDA Structured Product Labelling data for identification purposes. It is not medical advice and does not recommend, sell or price any medicine.